150 related articles for article (PubMed ID: 37780881)
1. Understanding the Constraints and Optimization of Serum Immunofixation Electrophoresis and Serum Free Light Chains for Detecting Monoclonal Proteins: A Single-Center Experience.
Shastri M; Malhotra P; Kaur H; Aggarwal R
J Lab Physicians; 2023 Dec; 15(4):518-523. PubMed ID: 37780881
[No Abstract] [Full Text] [Related]
2. A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies.
Kuriakose E; Narayanan Unni Cheppayil S; Kuzhikandathil Narayanan S; Vasudevan A
Indian J Clin Biochem; 2019 Jan; 34(1):76-81. PubMed ID: 30728676
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
Fulton RB; Fernando SL
Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
[TBL] [Abstract][Full Text] [Related]
4. Free light chain and intact immunoglobulin abnormalities in heart transplant recipients: Two year follow-up timelines and clinical correlations.
Sečník P; Lavríková P; Hošková L; Malíková P; Jabor A; Franeková J
Transpl Immunol; 2017 Mar; 41():22-26. PubMed ID: 28167270
[TBL] [Abstract][Full Text] [Related]
5. Is urine immunofixation electrophoresis necessary for monitoring myeloma patients who have undergone hematopoietic stem cell transplantation?
Sencar ME; Yıldız A; Haznedar R
Transfus Apher Sci; 2019 Dec; 58(6):102660. PubMed ID: 31734164
[TBL] [Abstract][Full Text] [Related]
6. Serum-free light chain test utilisation at a South African academic laboratory and comparison with serum protein electrophoresis results.
Banderker RB; Fazel FB; Zemlin AE; Khine AA; Jalavu TP
Afr J Lab Med; 2023; 12(1):2201. PubMed ID: 38058849
[TBL] [Abstract][Full Text] [Related]
7. Optimization of workflow and screening panels for the detection of malignant monoclonal gammopathies.
Oliveros Conejero R; Pascual Usandizaga P; Garrido Chércoles A
Adv Lab Med; 2020 Oct; 1(3):20200042. PubMed ID: 37361501
[TBL] [Abstract][Full Text] [Related]
8. Audit of the Prevalence of Noncorrelation of Immunofixation with Protein Electrophoresis and Serum Free Light Chain Assays in Multiple Myeloma in a Tertiary Cancer Care Center.
Paul C; Chakraborty S; Sugumar S; Bhattacharya R; Rath S; Chakraborty S
Indian J Clin Biochem; 2021 Jul; 36(3):353-359. PubMed ID: 34220011
[TBL] [Abstract][Full Text] [Related]
9. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G
J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios.
Singhal S; Vickrey E; Krishnamurthy J; Singh V; Allen S; Mehta J
Blood; 2009 Jul; 114(1):38-9. PubMed ID: 19411633
[TBL] [Abstract][Full Text] [Related]
12. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of serum free light chain in primary systemic amyloidosis].
Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
[TBL] [Abstract][Full Text] [Related]
14. Differences identified between serum and urine immunofixation electrophoresis.
Tracy E; Andrews DM; Constantin MA; Zhu Y
Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains.
Wilhite D; Arfa A; Cotter T; Savage NM; Bollag RJ; Singh G
Pract Lab Med; 2021 Nov; 27():e00256. PubMed ID: 34703870
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up.
Sečník P; Jabor A; Lavríková P; Sečník J; Malíková P; Pokorná E; Franeková J
Transpl Immunol; 2019 Dec; 57():101229. PubMed ID: 31398462
[TBL] [Abstract][Full Text] [Related]
18. Urine immunofixation electrophoresis and serum free light chain analyses benefit diagnosis of multiple myeloma in orthopedic patients with normal serum total proteins, creatinine, calcium, and hemoglobin.
Jia Z; Xia J; Lu Q
Lab Med; 2023 Dec; ():. PubMed ID: 38141202
[TBL] [Abstract][Full Text] [Related]
19. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
